Cefprozil: a review.
Cefprozil is a novel third generation, broad-spectrum oral cephalosporin with activity against a spectrum of aerobic gram-negative and positive bacteria, as well as certain anaerobes. The beta-lactamase stability of cefprozil may exceed that of other oral cephalosporins for some important pathogens. Cefprozil may be a suitable alternative to several other commonly used beta-lactams and cephalosporins in the treatment of mild to moderate upper and lower respiratory tract infections including sinusitis, otitis media, pharyngitis/tonsillitis, secondary bacterial infection of acute bronchitis, and acute bacterial exacerbations of chronic bronchitis, and skin and skin structure infections in children. Available data indicate the safety of cefprozil in both pediatric and adult population.
Bhargava
Sumit
S
Department of Paediatrics, All India Insitute of Medical Sciences, Ansari Nagar, New Delhi 110029. skkabra@hotmail.com
Lodha
Rakesh
R
Kabra
S K
SK
D001991:Bronchitis / Q000188:drug therapy; D002511:Cephalosporins / Q000494:pharmacology*; D006801:Humans; D010033:Otitis Media / Q000188:drug therapy; D010612:Pharyngitis / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D012852:Sinusitis / Q000188:drug therapy; D012874:Skin Diseases, Infectious / Q000188:drug therapy*; D000097670:Cefprozil
D002511:Cephalosporins; D000097670:Cefprozil